Steps for Initiating Electroconvulsive Therapy Treatment

Similar documents
New Patient Questionnaire

Medications and Children Disorders

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Appendix: Psychotropic Medication Reference Tables

USF Health Psychiatry Clinic. New Patient Questionnaire Adult

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

PSYCHIATRY INTAKE FORM

Schedule FDA & literature based indications

Welcome and thank you for choosing University of Florida Physicians!

Guide to Psychiatric Medications for Children and Adolescents

Dealing with a Mental Health Crisis

NEW PATIENT INTAKE FORM

Study Guidelines for Quiz #1

Adult Initial Assessment / Patient Questionnaire Page 1

Mental Health Intake Form

8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

Mental Health Intake Form

MO Medicaid Foster Care Drugs FY10-FY14

LAGUNA BEHAVIORAL Crown Valley Parkway, Suite 140 Phone: (949) Laguna Niguel, CA Fax: (949)

2015 Update on Psychotropics

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES

Depression. University of Illinois at Chicago College of Nursing

Psychiatric Medication Guide

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS

Patient History Form

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

Before you try another medication, try asking your DNA

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Treatment of Major Depressive Disorder

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

PSYCHIATRIC HISTORY 6. Are you currently seeing a therapist? (Name & contact phone#)

Children s Hospital Of Wisconsin

NorthSTAR. Pharmacy Manual

Mental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health

Texas Prior Authorization Program Clinical Edit Criteria

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

5151 Research Dr NW Huntsville, AL Ph Fax

Dual Diagnosis: Substance Abuse and Mental Illness

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only

Weighty Issues with Psychotropic Use in Adolescents and Young Adults

HCA BHS Prescribing Guidelines Committee - Approved Medications 2012

Patients considering TMS Therapy

Riding the Waves: Tools for the Management of Bipolar Disorder

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS

#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS

Psychiatric Evaluation Intake Form

Supplement: Tables and Figures

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED

UPDATE ON THE OUTPATIENT TREATMENT OF PSYCHIATRIC DISORDERS Amanda J. Williams, MD Grayson & Associates Montgomery, AL

ELEMENTAL CENTER MENTAL HEALTH INTAKE FORM

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

POSITIVE YOUTH CONCEPTS Child and Adolescent Therapy 24 Front Street, Suite 302 Exeter, NH

The clinical response to the same dose

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Class: Treatment with Medication:

Mental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP

LifePath Systems Medication and Laboratory Formulary

May 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:

Psychiatric Evaluation Intake Form

Germantown Private Psychiatry PLLC

OBJECTIVES PSYCHOTROPIC MEDICATIONS WHAT IS PSYCHOTROPIC MEDICATION?

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Creating Partnerships. Laine Young-Walker, MD

Briefly state the reason for this evaluation: Patient s Name: Sex: Male/Female (circle one) Date of Birth: Age: Patient s Social Security #

RAI-MDS 2.0 ASSESSMENT GUIDE FOR USE BY CANADIAN SQLI NURSING HOMES AND NEWFOUNDLAND AND LABRADOR HOMES

Psychiatric Medications. Positive and negative effects in the classroom

Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of.

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016

Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist

TREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD

Psychopharmacology & Clinical Practice: Helping or Hurting?

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities

Objectives: Lifetime prevalence. Neurotransmitters of interest

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Psychiatry Board Handouts

FINDING PEACE OF MIND

Child Intake Form. Guardian Information Section. Emergency Contact: Relationship: Phone: Insurance Information Section

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

Professional Practice Minutes September 7 th, 2016

Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University

Depression & Anxiety in Adolescents

Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you.

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR

Transcription:

Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral has been made, we will schedule the patient for an appointment with a physician who specializes in ECT treatment. The physician will evaluate the patient and conduct an assessment to see if they meet the criteria for receiving treatment. Patients will also see a medical physician on staff at El Camino Hospital, who will perform a physical, order labs and an EKG. The physician will then make the determination that the patient is medically cleared for the procedure. ECT is offered at the Mountain View campus. For additional information about the program, contact the ECT nurse coordinator: 650-962-5795. For more information about ECT at El Camino Hospital visit www.elcaminohospital.org/ect The referral form to be completed by the attending psychiatrist follows this page. 2015 El Camino Hospital E-0421_ECT_ReferralInfo Feb18

Electroconvulsive Therapy (ECT) Referral by the Community/Attending Psychiatrist Date: Time: (referral valid for 30 days) Patient: Date of Birth: Private Phone #: Referring Psychiatrist: MD/DO: Phone: Fax: Email: Are translation services required? Yes No Please include a copy of your last progress note that includes a complete mental status exam, safety assessment, and current treatment plan. Please include a copy of patient s updated demographics form and/or insurance card. Please sign the attached Informed Consent Review for Electroconvulsive Therapy (ECT) as the Community Psychiatrist ( Form A ). Your signature indicates you have evaluated the patient, considered alternative treatments, and determined that ECT is the least drastic option available to the patient at this time. Your patient is not taking medications (anticonvulsants/benzodiazepines) that will interfere with ECT treatments or you will work with the patient to taper off these medications after the assessment but prior to starting ECT. You have reviewed the ECT Welcome List with the patient, who has verbalized an understanding of the requirements. If your patient s acuity increases or you assess that the patient needs inpatient level care at any time during this process, contact the inpatient unit admissions coordinator at El Camino Hospital (650-940-7291) or send the patient to the emergency room. Evaluations for ECT can be arranged while the patient is admitted to the inpatient unit. Page 1 of 8

Identifying Data: Current and Past Psychiatric Diagnoses (circle appropriate specifiers): MDD: single episode / recurrent, moderate / severe, with / without psychotic features Bipolar I / II: current episode depressed / manic / mixed, with / without psychotic features Schizophrenia: Schizoaffective Disorder: Active CD / Substance Use Disorders: History of CD / Substance Use Disorders: PTSD GAD OCD Personality Disorders: Dementia MCI Other: Active Psychosocial Stressors: None Cognitive Functioning: Intact Evidence of Impairment (please elaborate) Page 2 of 8

Past Psychiatric History (hospitalizations, suicide attempts, ECT, Transcranial Magnetic Stimulation, Dialectical Behavioral Therapy, Partial Hospitalization Programs, and other therapies, including treatments considered and rejected): Social History (including current work status): Family Psychiatric History: None Current Medical Problems / Past Medical History / Past Surgical History: None Page 3 of 8

Current Psychiatric Medications: None Current Dose Adequate Trial Benefits / Side Effects Current Non-Psychiatric Medications/Vitamins/OTCs None Current Dose Current Non-Psychiatric Medications/Vitamins/OTCs Current Dose Page 4 of 8

Past Psychiatric Medication Trials: Antidepressants None Adequate Trial Highest Dose Tolerated (if known) Benefits / Side Effects Fluoxetine (Prozac) Sertraline (Zoloft) Paroxetine (Paxil) Escitalopram (Lexapro) Citalopram (Celexa) Fluvoxamine (Luvox) Vilazodone (Viibryd) Vortioxetine (Trintellix) Venlafaxine (Effexor) Desvenlafaxine (Pristiq) Duloxetine (Cymbalta) Levomilnacipran (Fetzima) Buproprion (Wellbutrin) Mirtazapine (Remeron) Selegiline (Deprynl, Emsam) Tranylcypromine (Parnate) Phenylzine (Nardil) Clomipramine (Anafranil) Page 5 of 8

Amitriptyline (Elavil) Desipramine (Norpramin) Imipramine (Tofranil) Past Psychiatric Medication Trials: Mood Stabilizers / Antipsychotics None Adequate Trial Highest Dose Tolerated (if known) Benefits / Side Effects Lamotrigine (Lamictal) Valproic acid (Depakote) Lithium Carbamazepine (Tegretol) Oxcarbazepine (Trileptal) Aripiprazole (Abilify) Ziprasidone (Geodon) Risperidone (Risperdal) Paliperidone (Invega) Quetiapine (Seroquel) Page 6 of 8

Olanzapine (Zyprexa) Lurasidone (Latuda) Asenapine (Saphris) iioperidone (Fanapt) Brexpiprazole (Rexulti) Clozapine (Clozaril) Haloperidol (Haldol) Other Medication Trials Benefits / Side Effects Psychostimulants: Ativan / Klonopin / Xanax / Valium Gabapentin (Neurontin) Buspirone (Buspar) Hydroxyzine ( Atarax / Vistaril ) Trazodone Page 7 of 8

Any additional Information you would like us to know: The ECT physicians will be consultants in the care of your patient. During the process of ECT your patient will be instructed to contact you for issues related to medication management and psychiatric emergencies. If you have questions about medications, ECT side effects or management of your patient during the treatment series, please feel free to contact our team at 650-962-5795. Print Attending or Community Attending or Community Date Time Psychiatrist name Psychiatrist signature Return by FAX to 650-962-5715 / Attention: ECT Program Coordinator. If you have questions you can reach the ECT Program Coordinator at 650-962-5795 Page 8 of 8

A: INFORMED CONSENT REVIEW ELECTROCONVULSIVE THERAPY TREATMENT (FOR VOLUNTARY PATIENTS) We, the undersigned physicians, have examined the patient and believe that all reasonable treatment modalities have been carefully considered, and that convulsive treatment is indicated and is the least drastic alternative available for this patient at this time. A: MD Signature, Attending or Community Psychiatrist Date Time A: MD Print, Attending or Community Psychiatrist B: MD Signature, ECT Treating Psychiatrist Date Time B: MD Print, ECT Treating Psychiatrist I have examined this patient, and he/she has the capacity to give, and has given, informed consent. C: MD Signature Date Time Consulting Board Certified or Board Eligible Psychiatrist or Neurologist C: MD Print Consulting Board Certified or Board Eligible Psychiatrist or Neurologist Form # 6893 A Rev 10/17

2500 Grant Road, Mountain View, CA 94040 Welcome to the El Camino Hospital Electroconvulsive Therapy Program The following guidelines apply to your participation in the program: Patient Initials We will need you to come to all of your treatments. If you are ill we would still like you to arrive for your treatment to be assessed. If you are unable to make it to your treatment, please call the following numbers as soon as possible: 650-940-7180 (There will be pre op staff there to take your call at 5:00 AM). Please understand that missed treatments can cause significant disruption in your progress and recovery from your illness, leading to relapse. We do not recommend nonrefundable vacations or absences be scheduled for at least 4-5 months. You are to be NPO after 10 PM the night before your treatment. This means no food, fluids, mints or gum after 10 in the evening. Smoking is not prohibited, but it can increase gastric secretions, thus increasing risks of anesthesia. You will need a responsible adult to pick you up from the hospital and then stay with you for 24 hours after the treatment. Some people need additional support even after the first 24 hours, although this is rare. You will not be allowed to drive until 14 days have passed since completing the acute treatment series. At that time, you are no longer prohibited from driving due to ECT, but you or your family may feel you still need more time to recover from the illness or ECT. You should not drive when you are feeling unsafe to drive. Even once the 14 day period has elapsed after the acute series, you cannot drive for 24 hours after subsequent ECTs. The number of treatment you receive is determined by your clinical progress rather than by a predetermined number. Your ECT treating psychiatrists can estimate the number of treatments or discuss average length of treatment for other patients at El Camino; the final determination of your treatment plan, however, is personalized and is in made weekly in consultation with the entire ECT team, based on your symptoms and side effects. Page 1 of 2

2500 Grant Road, Mountain View, CA 94040 When you are treated, you may require more than one seizure if the first seizure is not sufficiently long enough to be therapeutic. Permission from at least three other psychiatrists on the El Camino Hospital ECT Committee is required to exceed 30 treatments in a year or 15 treatments in a month. You will need to attend two ECT clinics every four weeks to sign consent forms that are required by the State of California. The consent clinics are on Tuesdays and Thursdays. You will be reminded Thursday the week prior to the week your clinics occur. The clinics take place in the Behavioral Health Services outpatient area in Mountain View. These visits are not optional, and treatment will be suspended if they are missed due to California State-mandated regulations. You will be asked for your list of medications before every treatment by the preoperative Nurses. Please have your current medication list prepared in advance to reflect any changes. Make sure to note any changes in medical, psychiatric, herbal and over-the-counter medications. Please do not take any medications that you have not previously discussed with your doctor in order to prevent using medications that might interfere with ECT or anesthesia. Arrival time for treatments is 5:45 AM to 6:00 AM. Although we try to accommodate some requests, we are not able to guarantee a particular day, or time of treatment given a number of considerations. You will need to continue seeing your community psychiatrist for medication management and/or therapy while undergoing ECT. Reports of clinic visits are sent to your outpatient psychiatrist. In order to be cleared for anesthesia, you will be scheduled to get medical clearance once a month from one of the internal medicine consultants at El Camino Hospital on the morning of treatment. If you have an HMO, you may be required to cover that fee yourself if accommodations cannot be arranged. If you feel you would like to have further discussions with the treatment team outside of the procedure itself, please feel free to contact Tamara Malcolm RN to schedule an appointment, which are usually available on Tuesday afternoons 650-962-5795. As part of our ongoing evaluation of the memory and cognitive effects of ECT, we would like to contact you and schedule a re-test three months after the completion of the acute phase of treatment. Your testing results will be shared with you and your community provider if desired. Page 2 of 2

2500 Grant Road, Mountain View, CA 94040 Patient Signature Date Time Support Person Signature Date Time Page 3 of 2